Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 223 entries
View as:

Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03976102 Org: User:
Start: 05/15/19 End: 02/27/23 Due: 02/27/24

Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01064180 Org: User:
Start: 05/31/02 End: 05/31/02 Due: 05/31/03

Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01674517 Org: User:
Start: 02/28/10 End: 02/28/10 Due: 02/28/11

Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01267396 Org: User:
Start: 09/30/06 End: 10/31/06 Due: 10/31/07

Pilot Study of DFN-11 Injection in Medication Overuse Headache

Phase: N/A Priority: Normal
NCT ID: NCT02583425 Org: User:
Start: 09/30/15 End: 11/30/16 Due: 11/30/17

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01161147 Org: User:
Start: 10/31/04 End: 12/31/04 Due: 12/31/05

Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01283867 Org: User:
Start: 11/30/07 End: 12/31/07 Due: 12/31/08

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01286701 Org: User:
Start: 01/31/02 End: 03/31/02 Due: 03/31/03

Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01045434 Org: User:
Start: 12/31/06 End: 03/31/07 Due: 03/31/08

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01155960 Org: User:
Start: 05/31/08 End: 07/31/08 Due: 07/31/09

Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01052792 Org: User:
Start: 05/31/06 End: 06/30/06 Due: 06/30/07

Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01161940 Org: User:
Start: 07/31/04 End: 09/30/04 Due: 09/30/05

Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01888289 Org: User:
Start: 07/31/01 End: 09/30/01 Due: 09/30/02

Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03702855 Org: User:
Start: 12/31/15 End: 12/31/15 Due: 12/31/16

Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01133483 Org: User:
Start: 04/30/07 End: 05/31/07 Due: 05/31/08

Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03696329 Org: User:
Start: 10/31/15 End: 11/30/15 Due: 11/30/16

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01503437 Org: User:
Start: 11/30/06 End: 12/31/06 Due: 12/31/07

Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01511731 Org: User:
Start: 10/31/98 End: 10/31/98 Due: 10/31/99

Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01161979 Org: User:
Start: 01/31/05 End: 03/31/05 Due: 03/31/06

Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01161927 Org: User:
Start: 07/31/04 End: 09/30/04 Due: 09/30/05

Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01132222 Org: User:
Start: 09/30/04 End: 10/31/04 Due: 10/31/05

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01146106 Org: User:
Start: 12/31/02 End: 12/31/02 Due: 12/31/03

Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01645384 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01511757 Org: User:
Start: 06/30/02 End: 07/31/02 Due: 07/31/03

Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01504503 Org: User:
Start: 10/31/09 End: 12/31/09 Due: 12/31/10